DGAP-Ad hoc: MEDISANA AG

DGAP-Adhoc: MEDISANA AG: Intent of public takeover offer from Xiamen Comfort Science & Technology Group Co., Ltd. for MEDISANA AG shares

Medisana AG / Key word(s): Takeover

18.12.2015 11:00

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Ad-hoc announcement

MEDISANA AG: Intent of public takeover offer from Xiamen Comfort Science & Technology Group Co., Ltd. for MEDISANA AG shares

Neuss, December 18, 2015 - The Xiamen Comfort Science & Technology Group Co., Ltd. ("Easepal"), today announced its intent to make a voluntary public takeover offer to the shareholders of MEDISANA AG ("MEDISANA", ISIN DE0005492540, WKN 549 254) through its German subsidiary Comfort Enterprise (Germany) GmbH.

The voluntary public takeover offer to the MEDISANA shareholders will be made at an offer price of 2.80 EUR cash per share. This represents a premium of 14.3% to MEDISANA's closing share price on December 17, 2015 and of 3.5% on the three-month volume weighted average price (XETRA).

Concurrently, Easepal has entered into an agreement to acquire a 75.31% stake in MEDISANA from a group of major shareholders. This group includes Medisana's largest shareholder and CEO Ralf Lindner as well as Medisana's chairman of the supervisory board, Thies Goldberg. Ralf Lindner indirectly will take a stake in the company by reinvesting as part of the transaction. Besides he will continue in his role as CEO.

The management board and the supervisory board welcome the offer subject to review of the offer document.

MEDISANA AG Jagenbergstrasse 19, 41468 Neuss, Germany Tel.: +49 (0) 2131 / 36 68 0 Fax: +49 (0) 2131 / 36 68 50 95 info@medisana.de www.medisana.de

UBJ. GmbH Kapstadtring 10, 22297 Hamburg T.: +49 (0) 40 6378 5410 F.: +49 (0) 40 6378 5423 ir@ubj.de www.ubj.de

18.12.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de

--------------------------------------------------------------------------- Language: English Company: Medisana AG Jagenbergstr. 19 41468 Neuss Germany Phone: +49 (0)2131-3668 5410 Fax: +49 (0)2131- 3668 5095 E-mail: info@medisana.de Internet: www.medisana.de ISIN: DE0005492540 WKN: 549254 Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------